In this retrospective study, we evaluated common hot spot gene mutations located downstream of EGFR signaling pathway, the potential prognostic value for KRAS, BRAF, PIK3CA and NRAS was assessed in 228 stage II-III colon cancer. This evidence concerns the gene KRAS and malignant colon neoplasm.